Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 12:05 AM
NCT ID:
NCT07063758
Eligibility Criteria:
Inclusion Criteria:
1. Age ≥ 20 y/o
2. Histologically confirmed urothelial carcinoma
3. Radiologically documented locally advanced or metastatic disease
4. Exposure to EV (as monotherapy or in combination with pembrolizumab) or first-line platinum-based chemotherapy
5. Complete and identifiable medical records
Exclusion Criteria:
1. Inadequate or insufficient tumor tissues for analyses
2. Incomplete medical records
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT07063758
Study Brief:
Protocol Section:
NCT07063758